These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
336 related articles for article (PubMed ID: 29791078)
1. Molecular subtype classification of urothelial carcinoma in Lynch syndrome. Therkildsen C; Eriksson P; Höglund M; Jönsson M; Sjödahl G; Nilbert M; Liedberg F Mol Oncol; 2018 Aug; 12(8):1286-1295. PubMed ID: 29791078 [TBL] [Abstract][Full Text] [Related]
2. Prevalence of Lynch syndrome among patients with upper urinary tract carcinoma in a Japanese hospital-based population. Ito T; Kono K; Eguchi H; Okazaki Y; Yamamoto G; Tachikawa T; Akagi K; Okada Y; Kawakami S; Morozumi M; Tamaru JI; Ishida H Jpn J Clin Oncol; 2020 Jan; 50(1):80-88. PubMed ID: 31665498 [TBL] [Abstract][Full Text] [Related]
3. Universal Point of Care Testing for Lynch Syndrome in Patients with Upper Tract Urothelial Carcinoma. Metcalfe MJ; Petros FG; Rao P; Mork ME; Xiao L; Broaddus RR; Matin SF J Urol; 2018 Jan; 199(1):60-65. PubMed ID: 28797715 [TBL] [Abstract][Full Text] [Related]
4. Upper tract urothelial carcinoma: a clinicopathologic study including microsatellite instability analysis. Blaszyk H; Wang L; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Hartmann A Mod Pathol; 2002 Aug; 15(8):790-7. PubMed ID: 12181263 [TBL] [Abstract][Full Text] [Related]
5. Clinicopathological characteristics of patients with upper urinary tract urothelial cancer with loss of immunohistochemical expression of the DNA mismatch repair proteins in universal screening. Urakami S; Inoshita N; Oka S; Miyama Y; Nomura S; Arai M; Sakaguchi K; Kurosawa K; Okaneya T Int J Urol; 2018 Feb; 25(2):151-156. PubMed ID: 29164703 [TBL] [Abstract][Full Text] [Related]
7. A proportion of hereditary upper urinary tract urothelial carcinomas are misclassified as sporadic according to a multi-institutional database analysis: proposal of patient-specific risk identification tool. Audenet F; Colin P; Yates DR; Ouzzane A; Pignot G; Long JA; Soulie M; Phé V; Bensadoun H; Guy L; Ruffion A; Valeri A; Cormier L; Droupy S; de La Taille A; Saint F; Faïs PO; Houlgatte A; Cussenot O; Rouprêt M; BJU Int; 2012 Dec; 110(11 Pt B):E583-9. PubMed ID: 22703159 [TBL] [Abstract][Full Text] [Related]
8. Urinary Tract Cancer in Lynch Syndrome; Increased Risk in Carriers of MSH2 Mutations. Joost P; Therkildsen C; Dominguez-Valentin M; Jönsson M; Nilbert M Urology; 2015 Dec; 86(6):1212-7. PubMed ID: 26385421 [TBL] [Abstract][Full Text] [Related]
9. Upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (lynch syndrome) tumor spectrum. Rouprêt M; Yates DR; Comperat E; Cussenot O Eur Urol; 2008 Dec; 54(6):1226-36. PubMed ID: 18715695 [TBL] [Abstract][Full Text] [Related]
10. Upper urinary tract urothelial carcinoma in eastern Taiwan: high proportion among all urothelial carcinomas and correlation with chronic kidney disease. Chen CY; Liao YM; Tsai WM; Kuo HC J Formos Med Assoc; 2007 Dec; 106(12):992-8. PubMed ID: 18194904 [TBL] [Abstract][Full Text] [Related]
11. Patients with Lynch syndrome mismatch repair gene mutations are at higher risk for not only upper tract urothelial cancer but also bladder cancer. Skeldon SC; Semotiuk K; Aronson M; Holter S; Gallinger S; Pollett A; Kuk C; van Rhijn B; Bostrom P; Cohen Z; Fleshner NE; Jewett MA; Hanna S; Shariat SF; Van Der Kwast TH; Evans A; Catto J; Bapat B; Zlotta AR Eur Urol; 2013 Feb; 63(2):379-85. PubMed ID: 22883484 [TBL] [Abstract][Full Text] [Related]
12. A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort. Marzouka NA; Eriksson P; Rovira C; Liedberg F; Sjödahl G; Höglund M Sci Rep; 2018 Feb; 8(1):3737. PubMed ID: 29487377 [TBL] [Abstract][Full Text] [Related]
13. [Molecular changes in development and progression of urothelial carcinoma]. Hartmann A Verh Dtsch Ges Pathol; 2003; 87():172-84. PubMed ID: 16888910 [TBL] [Abstract][Full Text] [Related]
14. Urothelial carcinoma of the upper urinary tract: inverted growth pattern is predictive of microsatellite instability. Hartmann A; Dietmaier W; Hofstädter F; Burgart LJ; Cheville JC; Blaszyk H Hum Pathol; 2003 Mar; 34(3):222-7. PubMed ID: 12673555 [TBL] [Abstract][Full Text] [Related]
15. Lynch syndrome and urologic malignancies: a contemporary review. Lim A; Rao P; Matin SF Curr Opin Urol; 2019 Jul; 29(4):357-363. PubMed ID: 31045926 [TBL] [Abstract][Full Text] [Related]
16. Lynch Syndrome: A Primer for Urologists and Panel Recommendations. Mork M; Hubosky SG; Rouprêt M; Margulis V; Raman J; Lotan Y; O'Brien T; You N; Shariat SF; Matin SF J Urol; 2015 Jul; 194(1):21-9. PubMed ID: 25711197 [TBL] [Abstract][Full Text] [Related]
17. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum. Mongiat-Artus P Eur Urol; 2008 Dec; 54(6):1235-6. PubMed ID: 18715693 [No Abstract] [Full Text] [Related]
18. Epidemiology of urothelial carcinoma. Miyazaki J; Nishiyama H Int J Urol; 2017 Oct; 24(10):730-734. PubMed ID: 28543959 [TBL] [Abstract][Full Text] [Related]
19. [Should we systematically screen for Lynch syndrome in patients with upper urinary tract carcinoma?]. Olagui GS; Pignot G; Rouquette A; Vieillefond A; Amsellem-Ouazana D; de Longchamps NB; Radenen B; Zerbib M; Terris B Bull Cancer; 2014 Feb; 101(2):144-50. PubMed ID: 24556207 [TBL] [Abstract][Full Text] [Related]
20. Editorial comment on: upper urinary tract urothelial cell carcinomas and other urological malignancies involved in the hereditary nonpolyposis colorectal cancer (Lynch syndrome) tumor spectrum. Burger M Eur Urol; 2008 Dec; 54(6):1236. PubMed ID: 18715704 [No Abstract] [Full Text] [Related] [Next] [New Search]